XWELL Inc (XWEL) USD0.01

Sell:$0.75Buy:$0.85$0.02 (2.86%)

Prices delayed by at least 15 minutes
Sell:$0.75
Buy:$0.85
Change:$0.02 (2.86%)
Prices delayed by at least 15 minutes
Sell:$0.75
Buy:$0.85
Change:$0.02 (2.86%)
Prices delayed by at least 15 minutes

Company Information

About this company

XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio-surveillance program. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

Key people

Ezra T. Ernst
Chief Executive Officer
Ian Brown
Chief Financial Officer
Bruce T. Bernstein
Independent Chairman of the Board
Michael Lebowitz
Independent Director
Robert Weinstein
Independent Director
Gaeelle S. Wizenberg
Independent Director
Click to see more

Key facts

  • EPIC
    XWEL
  • Location
    United States
  • Sector
    Services
  • Industry
    Personal Services
  • ISIN
    US98420U8027
  • Market cap
    $4.05m
  • Employees
    246
  • Shares in issue
    5.26m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.